Fontana V - Search Results

1

Effect of tamoxifen on endometrial proliferation.

Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A. Decensi A, et al. Among authors: fontana v. J Clin Oncol. 1996 Feb;14(2):434-40. doi: 10.1200/JCO.1996.14.2.434. J Clin Oncol. 1996. PMID: 8636754

2

The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1.

Torrisi R, Pensa F, Fontana V, Costa A, Decensi A. Torrisi R, et al. Among authors: fontana v. Eur J Cancer. 1995;31A(3):420-1. doi: 10.1016/0959-8049(94)00524-9. Eur J Cancer. 1995. PMID: 7786612 No abstract available.

3

Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.

Torrisi R, Parodi S, Fontana V, Rondanina G, Formelli F, Costa A, Boccardo F, Decensi A. Torrisi R, et al. Among authors: fontana v. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):507-10. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000302

4

Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?

Decensi A, Torrisi R, Fontana V. Decensi A, et al. Among authors: fontana v. Br J Cancer. 1994 Mar;69(3):617-9. doi: 10.1038/bjc.1994.115. Br J Cancer. 1994. PMID: 8123500 Free PMC article. Clinical Trial.

5

Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancer.

Decensi A, Torrisi R, Fontana V, Marroni P, Padovani P, Guarneri D, Minuto F, Boccardo F. Decensi A, et al. Among authors: fontana v. Acta Endocrinol (Copenh). 1993 Oct;129(4):315-21. doi: 10.1530/acta.0.1290315. Acta Endocrinol (Copenh). 1993. PMID: 8237249

6

Long-term effects of fenretinide on retinal function.

Decensi A, Fontana V, Fioretto M, Rondanina G, Torrisi R, Orengo MA, Costa A. Decensi A, et al. Among authors: fontana v. Eur J Cancer. 1997 Jan;33(1):80-4. doi: 10.1016/s0959-8049(96)00351-6. Eur J Cancer. 1997. PMID: 9071904 Clinical Trial.

7

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

Torrisi R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, De Palo G, Costa A, Decensi A. Torrisi R, et al. Among authors: fontana v. Int J Cancer. 1998 Jun 10;76(6):787-90. doi: 10.1002/(sici)1097-0215(19980610)76:6<787::aid-ijc3>3.0.co;2-u. Int J Cancer. 1998. PMID: 9626341

8

Socioeconomic status and survival of gastric cancer patients.

Fontana V, Decensi A, Orengo MA, Parodi S, Torrisi R, Puntoni R. Fontana V, et al. Eur J Cancer. 1998 Mar;34(4):537-42. doi: 10.1016/s0959-8049(97)10098-3. Eur J Cancer. 1998. PMID: 9713305

9

Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.

Decensi A, Torrisi R, Fontana V, Barreca A, Ponzani P, Pensa F, Parodi S, Costa A. Decensi A, et al. Among authors: fontana v. Eur J Cancer. 1998 Jun;34(7):999-1003. doi: 10.1016/s0959-8049(97)10170-8. Eur J Cancer. 1998. PMID: 9849446 Clinical Trial.

10

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer.

Decensi A, Torrisi R, Gozza A, Severi G, Bertelli G, Fontana V, Pensa F, Carozzo L, Traverso A, Milone S, Dini D, Costa A. Decensi A, et al. Among authors: fontana v. Breast Cancer Res Treat. 1999 Jan;53(2):145-51. doi: 10.1023/a:1006160523497. Breast Cancer Res Treat. 1999. PMID: 10326791 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters